Today: 4 March 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Historic Crypto Crash Aftermath: Binance’s $400M Payout Plan to “Rekt” Traders

Historic Crypto Crash Aftermath: Binance’s $400M Payout Plan to “Rekt” Traders

A surprise 100% tariff threat by Donald Trump triggered a crypto crash on Oct. 10–11, wiping out $19–20 billion in leveraged positions and liquidating over 1.6 million traders as Bitcoin plunged from $125,000 to $104,000. Binance suffered outages and de-pegged tokens, later reimbursing $283 million to affected users. Binance launched a $400 million recovery plan. Bitcoin has since rebounded above $111,000.
16 October 2025
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre shares fell about 5% to $2,048 on Oct. 15, 2025, after peaking near $2,500 last month. Q2 revenue beat forecasts at $6.8 billion, but net income missed due to heavy spending in Brazil. The company launched a B2B marketplace and entered Brazil’s pharmacy sector. MercadoPago’s credit portfolio nearly doubled year-over-year to $9.3 billion, with active fintech users up 30%.
16 October 2025
··
iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

iRobot shares surged 36% on Oct. 15, closing at $5.37 after hitting $6.09, the highest in seven months. Trading volume topped 7 million shares amid a short squeeze, with short interest at 26–28% of float. The rally came despite no major news and ongoing financial struggles, including falling revenue and warnings about the company’s future. iRobot is reviewing strategic options after the failed Amazon takeover.
16 October 2025
··
Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Sana Biotechnology shares jumped 26% to $5.62 on Oct. 15 after hedge fund manager Eric Jackson called the stock a potential “100-bagger” on X, triggering volatility halts. The rally followed early trial results showing transplanted pancreatic cells produced insulin without immunosuppressive drugs. Sana raised $105 million in summer 2025, extending its cash runway into late 2026. Analyst ratings remain mixed, with targets ranging from $5 to $12.
16 October 2025
··
Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Corp. (NASDAQ: UROY) hit a 52-week high near $4.87 this week before closing at $4.75, up 11% on the day and 85% year-on-year. The surge followed a surprise profitable quarter and record uranium prices above $80 per pound. Options volume spiked 1,590% above average as traders bet on further gains. Analyst ratings remain mixed, with a consensus “Hold” and a $4.50 price target.
16 October 2025
Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune Therapeutics shares surged 42% on October 8, 2025, after nearly doubling intraday on September 19, despite no major news and record trading volumes. The company sold its key T-cell therapy programs, including Tecelra, to US WorldMeds for $55 million upfront to pay off debt and avoid insolvency. Q2 net loss reached $30.3 million, with cash reserves at $26 million by mid-year. Analysts remain bearish, with no major buy ratings.
16 October 2025
··
Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi, via her husband’s trades, and Warren Buffett’s Berkshire Hathaway both hold Amazon, Apple, Visa, and American Express. As of mid-October 2025, Apple trades near $250 and Amazon at $215–$216. Pelosi’s Tempus AI bet surged to $92, up 185% since January. Pelosi’s portfolio returned 693% since 2014, more than double Buffett’s 304%, but fell 7.4% in the last year.
16 October 2025
····
Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Gold hit a record high near $4,243 per ounce this week, while silver reached an all-time peak of $53.60 before retreating. Both metals have soared in 2025, with gold up over 60% and silver rising as much as 80% year-to-date. Investors are buying amid economic uncertainty, U.S. rate cut expectations, and a supply squeeze in silver. Silver lease rates in London climbed to multi-decade highs.
16 October 2025
·
Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (NASDAQ:RDW) closed at about $9.40 on Oct. 15, down 1.5% after a 5.3% jump the previous day on news of a partnership with Red Cat. The stock remains volatile, falling 18.6% over the past week and down 42% year-to-date. CFO Jonathan Baliff will retire Nov. 30. Analysts’ 12-month price targets average $18–$19, with most ratings “Buy,” though Bank of America maintains an Underperform.
15 October 2025
··
HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

New Horizon Aircraft (NASDAQ: HOVR) closed at $3.91 on Oct 14, 2025, up 6.5% and near its 52-week high after announcing a deal to use Pratt & Whitney Canada’s PT6A engine for its Cavorite X7 hybrid eVTOL. Shares have surged about 28% since early October and now value the company at $150–160 million. Horizon reported no revenue in Q1 FY2026 but cited strong liquidity and technical milestones.
15 October 2025
···
Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab shares surged to around $72 on Oct. 15, 2025, up nearly 700% year-over-year and near all-time highs. The company secured major launch contracts with JAXA and Japanese satellite firms, including a record 10-launch deal with Synspective. Rocket Lab reported Q2 revenue of $144.5 million, up 36% from last year. Morgan Stanley raised its price target to $68, citing strong growth prospects.
15 October 2025
···
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion Pharmaceuticals’ stock jumped about 16% to $6.08 on Oct. 8, 2025, after renewed interest in its AI-driven drug discovery platform. The company reported Q2 revenue of $19.2 million and a net loss of $171.9 million, ending the quarter with $534 million in cash. Management cut 20% of staff in mid-2025 to reduce costs. Analyst targets average $6.50, with mixed ratings.
15 October 2025
···
Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia shares hit a 52-week high near $5.49 on Oct 14, then rose to $5.54 on Oct 15 after announcing major 5G contracts with Vodafone and Rakuten. The company’s Q2 sales beat expectations, though EPS missed slightly. Nokia’s board approved issuing 120 million new shares, raising the total to about 5.58 billion. Analyst consensus remains a Moderate Buy, with a $5.52 average target.
15 October 2025
··
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale Power’s stock surged 20.3% after its partner ENTRA1 signed a 6 GW SMR deployment deal with TVA, the largest such contract in U.S. history. The plan involves six 77-MWe NuScale reactors. Global SMR demand is rising, with utilities and tech firms backing new projects. NuScale remains unprofitable, burning about $95 million in cash per quarter as of mid-2025.
15 October 2025
···
Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar shares jumped 10.8% to $15.72 on Oct 14, breaking above their 200-day average after Goldman Sachs raised its price target and reports surfaced of possible Chinese curbs on solar panel overcapacity. The company posted a Q2 loss of $0.53 per share on $1.69 billion revenue, missing estimates. Canadian Solar launched new HiKu7 TOPCon panels and announced large battery storage projects in Ontario. Analyst consensus remains “Hold.”
15 October 2025
··
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk will pay up to $2.1 billion to license Omeros’s experimental MASP-3 inhibitor zaltenibart for rare blood and kidney disorders. Omeros receives $340 million upfront, with additional milestone and royalty payments possible. Omeros shares jumped about 65% on the news, while Novo’s stock fell 1.5%. The deal is expected to close by Q4 2025.
15 October 2025
···
Rare Earths Showdown: China’s ‘Bazooka’ Roils Markets, Trump Vows Tariffs

Rare Earths Showdown: China’s ‘Bazooka’ Roils Markets, Trump Vows Tariffs

China will ban or strictly license exports of 12 rare-earth elements starting Nov. 8, tightening controls on materials used in tech and defense. President Trump responded with 100% tariffs on all Chinese imports effective Nov. 1 and threatened to cancel a planned summit with Xi Jinping. U.S. Treasury Secretary Scott Bessent called China’s move “economic aggression.” Rare-earth stocks in both countries surged following the announcements.
15 October 2025
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

A federal judge on Oct. 14 upheld the U.S. government’s downgrade of Humana’s 2025 Medicare Advantage star rating from 4.5 to 3.5 stars, dismissing Humana’s lawsuit. The ruling leaves about 45% of Humana’s Medicare Advantage members in lower-rated plans and could cost the company an estimated $1 billion in lost federal bonus payments next year. Humana shares fell 3–4% on the news. The company said it may appeal.
15 October 2025
·
1 … 77 78 79 80 81 … 140
Go toTop